Archie Bleyer

16.9k total citations · 5 hit papers
116 papers, 8.6k citations indexed

About

Archie Bleyer is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Archie Bleyer has authored 116 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Pediatrics, Perinatology and Child Health, 62 papers in Public Health, Environmental and Occupational Health and 32 papers in Oncology. Recurrent topics in Archie Bleyer's work include Childhood Cancer Survivors' Quality of Life (64 papers), Acute Lymphoblastic Leukemia research (50 papers) and Adolescent and Pediatric Healthcare (21 papers). Archie Bleyer is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (64 papers), Acute Lymphoblastic Leukemia research (50 papers) and Adolescent and Pediatric Healthcare (21 papers). Archie Bleyer collaborates with scholars based in United States, Canada and United Kingdom. Archie Bleyer's co-authors include H. Gilbert Welch, Ronald D. Barr, Rebecca H. Johnson, Eric Tai, Elise D. Cook, Joseph M. Unger, Troy Budd, Michael Montello, Carey K. Anders and Jennifer K. Litton and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Archie Bleyer

110 papers receiving 8.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence

2012 946 citations Archie Bleyer et al. profile →
Breast Cancer Before Age 40 Years

2009 563 citations Rebecca H. Johnson, Archie Bleyer et al. Seminars in Oncology profile →
The distinctive biology of cancer in adolescents and young adults

2008 507 citations Archie Bleyer, Ronald D. Barr et al. profile →
The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies

2016 401 citations Joseph M. Unger, Elise D. Cook et al. American Society of Clinical Oncology Educational Book profile →
The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies

2016 303 citations Joseph M. Unger, Elise D. Cook et al. American Society of Clinical Oncology Educational Book profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Archie Bleyer United States	45	3.3k	3.3k	3.0k	1.2k	1.1k	116	8.6k
Theresa H.M. Keegan United States	57	4.7k 1.4×	3.4k 1.0×	2.6k 0.9×	1.3k 1.1×	1.2k 1.0×	295	10.9k
Lisa Diller United States	53	3.3k 1.0×	3.4k 1.0×	2.4k 0.8×	1.6k 1.4×	1.3k 1.2×	220	10.8k
Smita Bhatia United States	43	2.2k 0.7×	3.2k 1.0×	2.7k 0.9×	427 0.4×	1.0k 0.9×	359	8.4k
Peter Kaatsch Germany	44	1.6k 0.5×	3.9k 1.2×	3.3k 1.1×	703 0.6×	1.1k 1.0×	162	8.0k
Eve Roman United Kingdom	53	2.5k 0.8×	2.5k 0.8×	3.3k 1.1×	856 0.7×	624 0.5×	241	10.2k
Charles Stiller United Kingdom	63	3.4k 1.0×	5.5k 1.7×	5.2k 1.7×	968 0.8×	2.9k 2.6×	223	13.9k
Ann S. Hamilton United States	63	5.0k 1.5×	2.3k 0.7×	1.9k 0.6×	1.8k 1.5×	4.3k 3.8×	316	13.9k
Debra L. Friedman United States	46	2.2k 0.7×	5.8k 1.8×	3.8k 1.3×	273 0.2×	1.6k 1.4×	196	10.9k
Ravi Bhatia United States	85	5.9k 1.8×	4.4k 1.4×	4.5k 1.5×	1.2k 1.1×	2.1k 1.8×	463	21.8k
William L. Carroll United States	60	2.8k 0.8×	5.6k 1.7×	8.7k 2.9×	699 0.6×	707 0.6×	316	13.6k

Countries citing papers authored by Archie Bleyer

Since Specialization

Citations

This map shows the geographic impact of Archie Bleyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Archie Bleyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Archie Bleyer more than expected).

Fields of papers citing papers by Archie Bleyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Archie Bleyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Archie Bleyer. The network helps show where Archie Bleyer may publish in the future.

Co-authorship network of co-authors of Archie Bleyer

This figure shows the co-authorship network connecting the top 25 collaborators of Archie Bleyer. A scholar is included among the top collaborators of Archie Bleyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Archie Bleyer. Archie Bleyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bleyer, Archie, Lynn A. G. Ries, Danielle B. Cameron, et al.. (2025). Colon, colorectal, and all cancer incidence increase in the young due to appendix reclassification. JNCI Journal of the National Cancer Institute. 117(7). 1340–1349. 4 indexed citations

Geller, James I., Martine van Grotel, Marc Ansari, et al.. (2024). Local application of sodium thiosulfate as an otoprotectant for cisplatin-exposed patients – A narrative literature review to explore the potential benefit for children with cancer. SHILAP Revista de lepidopterología. 5. 100211–100211.

Ansari, Marc, Éric Bouffet, Archie Bleyer, et al.. (2024). Use of Sodium Thiosulfate as an Otoprotectant in Patients With Cancer Treated With Platinum Compounds: A Review of the Literature. Journal of Clinical Oncology. 42(18). 2219–2232. 8 indexed citations

Heuvel‐Eibrink, Marry M. van den, et al.. (2024). Prevention of cisplatin-induced hearing loss in children: achievements and challenges for evidence-based implementation of sodium Thiosulfate. Frontiers in Oncology. 14. 1336714–1336714. 7 indexed citations

Bleyer, Archie, et al.. (2024). Fallacy of attributing the U.S. firearm mortality epidemic to mental health. PLoS ONE. 19(8). e0290138–e0290138.

Bleyer, Archie, et al.. (2024). United States marijuana legalization and opioid mortality trends before and during the first year of the COVID-19 pandemic. Journal of Opioid Management. 20(2). 119–132. 1 indexed citations

Brock, Penelope, Per Kogner, Marc Ansari, et al.. (2023). Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use it. Pediatric Blood & Cancer. 70(5). e30248–e30248. 13 indexed citations

Cathcart-Rake, Elizabeth, Kathryn J. Ruddy, Archie Bleyer, & Rebecca H. Johnson. (2021). Breast Cancer in Adolescent and Young Adult Women Under the Age of 40 Years. JCO Oncology Practice. 17(6). 305–313. 104 indexed citations

Cuglievan, Branko, Amy M. Berkman, Seyedeh Dibaj, et al.. (2020). Impact of Lagtime, Health Insurance Type, and Income Status at Diagnosis on the Long-Term Survival of Adolescent and Young Adult Cancer Patients. Journal of Adolescent and Young Adult Oncology. 10(2). 164–174. 18 indexed citations

10.

Bleyer, Archie & Theresa H.M. Keegan. (2018). Incidence of malignant lymphoma in adolescents and young adults in the 58 counties of California with varying synthetic turf field density. Cancer Epidemiology. 53. 129–136. 11 indexed citations

11.

Unger, Joseph M., Elise D. Cook, Eric Tai, & Archie Bleyer. (2016). The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies. American Society of Clinical Oncology Educational Book. 185–198. 401 indexed citations breakdown →

12.

Beaupin, Lynda K., et al.. (2016). Pegaspargase hypersensitivity reactions: intravenous infusion versus intramuscular injection – a review. Leukemia & lymphoma. 58(4). 766–772. 11 indexed citations

13.

Bleyer, Archie, et al.. (2014). Clinical application of asparaginase activity levels following treatment with pegaspargase. Pediatric Blood & Cancer. 62(6). 1102–1105. 32 indexed citations

14.

Hubbard, Joleen M., David M. Thomas, Greg Yothers, et al.. (2012). Benefits and Adverse Events in Younger Versus Older Patients Receiving Adjuvant Chemotherapy for Colon Cancer: Findings From the Adjuvant Colon Cancer Endpoints Data Set. Journal of Clinical Oncology. 30(19). 2334–2339. 32 indexed citations

15.

Bleyer, Archie. (2011). Latest Estimates of Survival Rates of the 24 Most Common Cancers in Adolescent and Young Adult Americans. Journal of Adolescent and Young Adult Oncology. 1(1). 37–42. 81 indexed citations

16.

Bleyer, Archie, et al.. (2011). Trailblazers in Adolescent and Young Adult Oncology. Journal of Adolescent and Young Adult Oncology. 1(1). 13–18. 7 indexed citations

17.

Bleyer, Archie. (2009). Adolescent and young adult (aya) cancers: distinct biology, different therapy?. Cancer Forum. 33(1). 4. 6 indexed citations

18.

Bleyer, Archie & Ronald D. Barr. (2009). Introduction—Impact of Malignant Diseases on Young Adults II. Seminars in Oncology. 36(5). 380–380. 9 indexed citations

19.

Ferrari, Andrea & Archie Bleyer. (2007). Participation of adolescents with cancer in clinical trials. Cancer Treatment Reviews. 33(7). 603–608. 86 indexed citations

20.

Furman, Wayne L., Xiaolong Luo, Diane Fairclough, et al.. (1997). Phase I trial of subcutaneous interleukin-1α in children with malignant solid tumors. Medical and Pediatric Oncology. 28(6). 444–450. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact